Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab

被引：5

作者：

Disel, U.

Paydas, S. ^{[1
]}

Yavuz, S.

Karakoc, E.

机构：

[1] Cukurova Univ, Fac Med, Dept Oncol, TR-01330 Adana, Turkey

来源：

CHEMOTHERAPY | 2010年 / 56卷 / 02期

关键词：

Fludarabine; Pulmonary toxicity; Rituximab; CHRONIC LYMPHOCYTIC-LEUKEMIA; INTERSTITIAL PNEUMONITIS; FOLLICULAR LYMPHOMA; PHASE-II; THERAPY; CLL;

D O I：

10.1159/000305255

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Fludarabine is a nucleoside analogue used in the treatment of low-grade lymphoproliferative disorders and in conditioning regimens of non-myeloablative allogeneic stem cell transplantation. This is a relatively safe drug for clinical use but may cause side effects, some of which may be life-threatening. Here a case of severe pulmonary toxicity associated with fludarabine and a possible contribution of rituximab is presented and the literature reviewed. Copyright (C) 2010 S. Karger AG, Basel

引用

页码：89 / 93

页数：5

共 50 条

[1] PULMONARY TOXICITY ASSOCIATED WITH FLUDARABINE MONOPHOSPHATE
HURST, PG
HABIB, MP
GAREWAL, H
BLUESTEIN, M
PAQUIN, M
GREENBERG, BR
INVESTIGATIONAL NEW DRUGS, 1987, 5 (02) : 207 - 210
[2] PULMONARY TOXICITY AND ACUTE RESPIRATORY-FAILURE ASSOCIATED WITH FLUDARABINE MONOPHOSPHATE
KANE, GC
MCMICHAEL, AJ
PATRICK, H
ERSLEV, AJ
RESPIRATORY MEDICINE, 1992, 86 (03) : 261 - 263
[3] Fludarabine: pulmonary toxicity in patients with CLL
Reactions Weekly, 2002, 923 (1) : 3 - 3
[4] Corticosteroid responsive fludarabine pulmonary toxicity
Stoica, GS
Greenberg, HE
Rossoff, LJ
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (04): : 340 - 341
[5] Corticosteroid-Responsive Pulmonary Toxicity Associated with Fludarabine Monophosphate: A Case Report
Rudzianskiene, Milda
Griniute, Rasa
Juozaityte, Elona
Inciura, Arturas
Rudzianskas, Viktoras
Kiavialaitis, Greta Emilia
TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (04) : 392 - 396
[6] Fludarabine associated pulmonary toxicity in chronic lymphoproliferative disorders; A case series.
Ales, NC
Helman, DL
Shorr, AF
Byrd, JC
BLOOD, 2000, 96 (11) : 756A - 757A
[7] Obliterative bronchiolitis after rituximab administration: a new manifestation of rituximab-associated pulmonary toxicity
Shen, T.
Braude, S.
INTERNAL MEDICINE JOURNAL, 2012, 42 (05) : 597 - 599
[8] Severe prolonged immunosuppression following fludarabine and rituximab combination therapy
Hudson, Emma
Westmoreland, Diana
Gorman, Christopher
Poynton, Christopher H.
Lester, Jason F.
Maughan, Timothy S.
CHEMOTHERAPY, 2008, 54 (03) : 242 - 244
[9] Fludarabine, Cyclophosphamide and Rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia
Vladimir, Lazarevic L. J.
Maria, Liljeholm
Karin, Forsberg
Stefan, Soederberg
Anders, Wahlin
LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1209 - 1211
[10] Successful treatment of fludarabine-associated paraneoplastic pemphigus with rituximab
Chang, Shurong
Konia, Thomas
Bagheri, Sepdieh
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB63 - AB63

← 1 2 3 4 5 →